From vitamin K antagonism to novel oral anticoagulants: basic concept
EHA Library. Schulman S. 06/13/14; 55593
Topic: 6Cb Anticoagulant and thrombolytic therapy in other medical conditions Disclosure(s): Research grants from Baxter, Octapharma
Prof. Sam Schulman
Contributions
Contributions
About this activity
Learning Objectives
This material is reviewed and approved by the ELC Editorial Board
After viewing this presentation the participant will be able to:
• Understand the drug development process of oral anticoagulants.
• Describe the common features of the new oral anticoagulants.
• Describe potential benefits of the new anticoagulants based on their pharmacological characteristics.
• Understand the drug development process of oral anticoagulants.
• Describe the common features of the new oral anticoagulants.
• Describe potential benefits of the new anticoagulants based on their pharmacological characteristics.
{{ help_message }}
{{filter}}